Evidence map›Paper›PMID 25210797›Full record

ArticleCell death & disease2014

HIPK2 sustains apoptotic response by phosphorylating Che-1/AATF and promoting its degradation.

F De Nicola, V Catena, C Rinaldo, T Bruno, S Iezzi, C Sorino, A Desantis, S Camerini, M Crescenzi, A Floridi and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity.Journal of experimental & clinical cancer research : CR · 2021
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

F De NicolaEpigenetics Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
V Catena1] Epigenetics Laboratory, Regina Elena National Cancer Institute, Rome, Italy [2] Department of Biothecnological and Applied Clinical Science, University of L'Aquila, Aquila, Italy.
C Rinaldo1] Institute of Molecular Biology and Pathology, National Research Council (CNR), c/o Sapienza University of Rome, Rome, Italy [2] Experimental Oncology Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
T BrunoEpigenetics Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
S IezziEpigenetics Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
C SorinoEpigenetics Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
A DesantisEpigenetics Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
S CameriniDepartment of Cell Biology and Neurosciences, Higher Institute of Health (ISS), Rome, Italy.
M CrescenziDepartment of Cell Biology and Neurosciences, Higher Institute of Health (ISS), Rome, Italy.
A FloridiEpigenetics Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
C PassanantiInstitute of Molecular Biology and Pathology, National Research Council (CNR), c/o Sapienza University of Rome, Rome, Italy.
S SodduExperimental Oncology Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
M FanciulliEpigenetics Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
Institute of Molecular Biology and Pathology · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Che-1/AATF is an RNA polymerase II-binding protein that is involved in the regulation of gene transcription, which undergoes stabilization and accumulation in response to DNA damage. We have previously demonstrated that following apoptotic induction, Che-1 protein levels are downregulated through its interaction with the E3 ligase HDM2, which leads to Che-1 degradation by ubiquitylation. This interaction is mediated by Pin1, which determines a phosphorylation-dependent conformational change. Here we demonstrate that HIPK2, a proapoptotic kinase, is involved in Che-1 degradation. HIPK2 interacts with Che-1 and, upon genotoxic stress, phosphorylates it at specific residues. This event strongly increases HDM2/Che-1 interaction and degradation of Che-1 protein via ubiquitin-dependent proteasomal system. In agreement with these findings, we found that HIPK2 depletion strongly decreases Che-1 ubiquitylation and degradation. Notably, Che-1 overexpression strongly counteracts HIPK2-induced apoptosis. Our results establish Che-1 as a new HIPK2 target and confirm its important role in the cellular response to DNA damage.

Indexed as

ApoptosisApoptosis Regulatory ProteinsCarrier ProteinsDNA DamageHumansPhosphorylationProtein BindingProtein Serine-Threonine KinasesProteolysisRepressor ProteinsUbiquitinUbiquitinationAATF protein, humanApoptosis Regulatory ProteinsCarrier ProteinsHIPK2 protein, humanProtein Serine-Threonine KinasesRepressor ProteinsUbiquitin

Identifiers

PMID25210797
PMCPMC4225224
OpenAlexW2044226709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.